Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mRNA generates two highly homologous isoforms, termed hGR alpha and hGR beta. hGR alpha is a ligand-activated transcription factor which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes by binding to specific glucocorticoid response element (GRE) DNA sequences. In contrast, hGR beta does not bind glucocorticoids and is transcriptionally inactive. We demonstrate here that hGR beta is able to inhibit the effects of hormone-activated hGR alpha on a glucocorticoid-responsive reporter gene in a concentration-dependent manner. [3H]-Dexamethasone binding studies indicate that hGR beta does not alter the affinity of hGR alpha for its hormonal ligand. The presence of hGR beta in nuclear extracts and its ability to bind to a radiolabeled GRE oligonucleotide suggest that its inhibitory effect may be due to competition for GRE target sites. Reverse transcription-PCR analysis shows expression of hGR beta mRNA in multiple human tissues. These results indicate that hGR beta may be a physiologically and pathophysiologically relevant endogenous inhibitor of glucocorticoid action, which may participate in defining the sensitivity of target tissues to glucocorticoids. They also underline the importance of distinguishing between the two receptor isoforms in all future studies of hGR function and the need to revisit old data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These GR variants are derived from a single gene by alternative splicing and alternative translation initiation mechanisms.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exon 2 forms the N-terminal domain of GR, exon 3–4 constitute the central DBD, while exons 5–9 code for the hinge and ligand-binding domain.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternative splicing at exon 9 of primary GR transcript generates two highly homologous mRNA transcripts that results in the production of two GR isoforms termed GRα and GRβ (Fig.3A)43, 44.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The conventional belief that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a diverse collection of receptor isoforms.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The GR protein is encoded by the Nr3c1 gene and consists of 9 exons; exon 1 forms the 5’-untranslated region, while exon 2–9 code for the GR protein.”
From Corticosteroids (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“48 h after transfection, cells were washed twice with PBS, and nuclear extracts were prepared essentially as described elsewhere (18).”
MethodThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 3×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160 · cited 1×
“its transcriptionally active counterpart, and, therefore, fits the definition of a dominant negative inhibitor of hGRa (20).”
Background
Cited by
Items 601–640 of 640
Psychosocial Stress and Addison's Disease
Wolf, J. M. (2006)
Prenzel, T. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-443
Stress, Glucocorticoids, and the Brain
DeRijk, R. H., & de Kloet, E. R. (2006) · Humana Press eBooks · doi:10.1385/1-59259-952-4:111
Sudsaward, S. (2018) · University of Salford Institutional Repository (University of Salford)
Improving Glucocorticoid Therapy in Chronic Lymphocytic Leukemia
Tung, S. (2013) · TSpace (University of Toronto)
An investigation of glucocorticoid and serotonergic systems in human placenta
Bivol, S. (2018) · Griffith Research Online · doi:10.25904/1912/494
Camacho, M. B. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Nathan, A., Brar, K., Valsan, A., Mohan, N. K., & Singh, G. (2019) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v6i3.08
Resende, A. T. P. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-17102018-131626
The Role of the Glucocorticoid Receptor Signalling Pathway within the Human Endometrium
Thomas, S. J. (2019) · Cronfa (Swansea University) · doi:10.23889/suthesis.50584
Kuipa, M. (2019) · Open University of Cape Town (University of Cape Town)
Munir, M. A., Agarwal, S., & Zhang, J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4836-7.00059-6
Huang, R., Zhan, Q., Hu, W., Yang, R., Cheng, N., & Han, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-87796/v1
“CpG islands located in the proximal promoter of NR3C1, MTHFR and IGFBP3 gene were selected for measurement according to the following criteria: (1) 200 bp minimum length; (2) 50% or higher GC content; (3) 0.”
BackgroundMethodThe mechanism of glucocorticoid induced murine thymocyte and peripheral T cell apoptosis
Wang, D. (2006) · Online Publication Service of Würzburg University (Würzburg University)
Estrategias para revertir la inmunosupresión en el fenómeno de tolerancia a endotoxinas
Barbara, R. (2011) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Schulte, H. M., Bamberger, A., & Bamberger, C. M. (2001) · Springer eBooks · doi:10.1007/978-3-642-56858-9_6
Self-citationMechanisms of steroid-refractory disease
Franchimont, D. P. (2007) · Springer eBooks · doi:10.1007/1-4020-2912-8_24
Oakley, R. H., Lewis‐Tuffin, L. J., Malchoff, C. D., Malchoff, D. M., & Cidlowski, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00098-8
Glucocorticoid Resistance Syndromes and States
Nicolaides, N. C., & Chrousos, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95741-6
Self-citationMechanisms of steroid action and resistance in inflammatory bowel disease
Kelleher, D. P., & McManus, R. (2007) · Springer eBooks · doi:10.1007/1-4020-4316-3_11
Multi-site therapeutic modalities for inflammatory bowel diseases — mechanisms of action
Rogler, G. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_26
Suboptimal Health and the Economic Impact to Healthcare from the Perspective of PPP Medicine
Garcia, M., & Wang, W. (2024) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-46891-9_4 · Cited by 2
Interplay Between Serotonin Transporter and Glucocorticoid Receptor on Anxiety and Depression
Padovan, C. M., Tirapelli, C. R., Campos‐Cardoso, R., & Souza, C. D. D. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_19-1 · Cited by 1
Nicolaides, N. C., Charmandari, E., & Chrousos, G. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00219-3
Self-citationInterplay Between Serotonin Transporter and Glucocorticoid Receptor on Anxiety and Depression
Padovan, C. M., Tirapelli, C. R., Campos‐Cardoso, R., & Souza, C. D. D. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_19 · Cited by 1
Bertotto, L. B., Sakoulas, E. M., Logrip, M. L., Lin, K., Pimentel, A. E., Thompson, L., Cruz, B., Vozella, V., Favoretto, C. A., Roberto, M., et al. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100770
“…receptor (GR α ; nuclear receptor subfamily 3 group C member 1, Nr3c1a ) or its truncated splice variant GR β , that has distinct, opposing actions ( Nr3c1b ) (Bamberger et al., 1995; Fruchter et al., 2005; Kino et al., 2009), correlated with defeat submission latency or drinking behavior.”
Koloskova, O. O., Аркадьевич, Н. А., Shilovskiy, I. P., Гудима, Г. О., Tahanovich, A. D., Kadushkin, A. G., Ishchanka, A., Shchurok, I., Aliakhnovich, N. S., Shershakova, N. N., et al. (2025) · Immunologiya · doi:10.33029/0206-4952-2025-46-5-663-677 · Cited by 1
Multi-site therapeutic modalities for inflammatory bowel diseases — mechanisms of action
Rogler, G. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_26
THE ROLE OF SCAVENGER RECEPTOR CLASS B TYPE I-REGULATED INDUCIBLE GLUCOCORTICOIDS IN SEPSIS
Ai, J. (2014) · UKnowledge (University of Kentucky)
Huang, J.-W., Yang, Y.-F., Gao, X., & Xu, Z.-H. (2023) · Figshare · doi:10.6084/m9.figshare.23543212
Glucocorticoid resistance syndromes and states
Nicolaides, N. C., & Chrousos, G. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00252-1
Self-citationImplication du récepteur des glucocorticoïdes en physiopathologie humaine
Vitellius, G. (2019) · theses.fr (ABES) · doi:10.70675/84630f11zbc82z43a6z8604z69024f4ae7dd
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
Delangre, E. (2021) · theses.fr (ABES) · doi:10.70675/622d48edz59dcz427ez85c9z9da5f8129e84
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Martinez, G. J., Kipp, Z. A., Bates, E. A., Pauss, S. N., Marino, J. S., & Hinds, T. D. (2026) · Livers · doi:10.3390/livers6040064
“Resistance often occurs when GR β levels exceed those of GR α [30,52,53], but the impact of this imbalance on glucocorticoid signaling when GR β predominates remains unclear.”
Molekulare Mechanismen der Glukokortikoidtherapie
Trapp, T., & Holsboer, F. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_4
Modulation of glucocorticoid activity by metabolism of steroids in non-lymphoid organs
Walker, B. R. (1997) · Springer eBooks · doi:10.1007/978-1-4471-0931-0_4
Metadata
- Authors
- Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2435-2441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295915
- OpenAlex
- W1974791065
- Cited by
- 642
- References
- 41
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 25 · 2018: 21 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 16 · 2012: 18
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor beta, glucocorticoid receptor alpha, alternative splicing, receptor isoforms, glucocorticoid response element, transcriptional repression, dexamethasone binding, glucocorticoid sensitivity
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Chlorocebus aethiops, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Proteins, Regulatory Sequences, Nucleic Acid, RNA, Messenger, Transcription, Genetic, Gene Expression, Alternative Splicing, DNA Primers, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.